Equine monitoring tech is advancing, but validation still lags

A new review in Equine Veterinary Journal takes stock of where equine welfare and performance monitoring stands under field conditions, and its conclusion is both encouraging and cautionary: the technology base is expanding fast, but the evidence behind many tools still varies by parameter and use case. The paper, published online ahead of print on September 6, 2025, focuses on technologies that can quantify both physiological and psychological responses to exercise, reflecting a broader shift toward objective welfare assessment in horses used for sport and training. (pubmed.ncbi.nlm.nih.gov)

That framing matters because equine sport is under sustained pressure to demonstrate welfare safeguards. The review explicitly links better monitoring to the ongoing debate over equestrian sport’s social licence to operate, and argues that welfare can’t be judged by performance metrics alone. Instead, it calls for a more comprehensive picture that includes cardiovascular, respiratory, muscular, thermoregulatory, endocrine, and locomotory systems, alongside indicators that may help capture affective or psychological state. (pubmed.ncbi.nlm.nih.gov)

In practical terms, the review highlights a market and research environment that has matured over the past two decades, with more tools now available for field use. Commercial products help show how that is playing out. Horsepal, for example, has marketed connected monitoring tools that combine heart rate sensing with movement, sleep, GPS, geofencing, environmental tracking, and app-based record sharing. Its materials also position the platform as a coordination tool among veterinarians, farriers, trainers, riders, and pet parents. That speaks to one of the field’s biggest attractions: continuous, shareable data outside the clinic. (taoglas.com)

But the review’s central point is that availability is not the same as validation. The authors say their focus is on technologies whose accuracy and precision have actually been determined, which suggests a meaningful gap between what is commercially possible and what is clinically dependable. That caution is echoed elsewhere in the literature. For example, commentary on skin-temperature monitoring during field exercise has noted that while continuous skin temperature is easy to capture, it does not always reliably predict core temperature dynamics, underscoring the risk of overinterpreting convenient proxy measures. (pubmed.ncbi.nlm.nih.gov)

Industry and professional groups are moving in the same direction. AAEP announced funding for a 2025 wearable biometric sensor study evaluating six manufacturers’ systems for their ability to detect gait changes associated with musculoskeletal injury risk in racehorses. EquiManagement has also reported on how regulators and industry groups are using stride sensors, imaging, and AI-assisted screening to identify horses that may need further evaluation before racing. Together, those efforts suggest the sector is trying to turn wearables from wellness accessories into tools with clearer clinical and regulatory value. (aaep.org)

Why it matters: For veterinary professionals, this is a signal that objective monitoring is moving closer to routine equine care, but not yet to the point where data should be accepted uncritically. The near-term opportunity is in longitudinal trend tracking: spotting changes in stride, workload response, heart rate recovery, rest patterns, or environmental stress that can inform exams, diagnostics, and management plans. The challenge is deciding which metrics are robust enough to influence medical decision-making, and which remain best treated as prompts for closer clinical assessment rather than stand-alone evidence. (pubmed.ncbi.nlm.nih.gov)

There’s also a workflow implication. As more platforms promise cloud sharing and cross-device access, veterinarians may increasingly be asked to interpret client-generated data from consumer apps and wearables. That could improve communication with pet parents and trainers, but it also raises familiar questions around data quality, standardization, and signal-to-noise ratio. Inference: the practices that benefit most may be the ones that set clear expectations early about what data they will review, how they’ll use it, and when a device alert does, or doesn’t, justify a clinical workup. That inference is supported by the review’s emphasis on validated measurement and by industry efforts to define where sensors fit in risk detection pathways. (pubmed.ncbi.nlm.nih.gov)

What to watch: The next phase will likely center on validation studies, clearer clinical thresholds, and integration into injury-prevention and welfare-assessment programs. If more devices can show repeatable accuracy under true field conditions, equine practice could move from episodic observation toward more continuous, data-informed care. (pubmed.ncbi.nlm.nih.gov)